Fundraising Fox
Neuroclues
Louvain-la-Neuve, BE · Founded 2020 · 34 employees on LinkedIn · 3 known investors
Find your way into Neuroclues
Sign up to see every warm intro you have to Neuroclues
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuroclues team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neuroclues develops eye-tracking technology to identify neurological disorders including Parkinson's, Alzheimer's, and Multiple Sclerosis before symptoms appear, serving clinicians and healthcare practitioners. The company combines hardware, software, and cloud systems to provide biomarkers for early disease detection.
Founders & leadership
Neuroclues was founded in 2020 by Pierre Daye, Pierre Pouget, and Antoine Pouppez.
Board
Investors · 3
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Teampact.ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Neuroclues do?
- Neuroclues develops eye-tracking technology to identify neurological disorders including Parkinson's, Alzheimer's, and Multiple Sclerosis before symptoms appear, serving clinicians and healthcare practitioners. The company combines hardware, software, and cloud systems to provide biomarkers for early disease detection.
- Who founded Neuroclues?
- Neuroclues was founded by Pierre Daye, Pierre Pouget, Antoine Pouppez in 2020.
- Who are Neuroclues's investors?
- Neuroclues's investors include Graph Ventures, Teampact.ventures, White Fund.
- Where is Neuroclues headquartered?
- Neuroclues is headquartered in Louvain-la-Neuve, BE.